1. Home
  2. TARS vs KLIC Comparison

TARS vs KLIC Comparison

Compare TARS & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • KLIC
  • Stock Information
  • Founded
  • TARS 2016
  • KLIC 1951
  • Country
  • TARS United States
  • KLIC United States
  • Employees
  • TARS N/A
  • KLIC N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • KLIC Semiconductors
  • Sector
  • TARS Health Care
  • KLIC Technology
  • Exchange
  • TARS Nasdaq
  • KLIC Nasdaq
  • Market Cap
  • TARS 1.7B
  • KLIC 1.7B
  • IPO Year
  • TARS 2020
  • KLIC N/A
  • Fundamental
  • Price
  • TARS $69.09
  • KLIC $39.86
  • Analyst Decision
  • TARS Strong Buy
  • KLIC Strong Buy
  • Analyst Count
  • TARS 7
  • KLIC 3
  • Target Price
  • TARS $67.14
  • KLIC $48.33
  • AVG Volume (30 Days)
  • TARS 737.2K
  • KLIC 510.3K
  • Earning Date
  • TARS 11-12-2025
  • KLIC 11-12-2025
  • Dividend Yield
  • TARS N/A
  • KLIC 2.05%
  • EPS Growth
  • TARS N/A
  • KLIC N/A
  • EPS
  • TARS N/A
  • KLIC 0.11
  • Revenue
  • TARS $295,521,000.00
  • KLIC $657,842,000.00
  • Revenue This Year
  • TARS $137.28
  • KLIC N/A
  • Revenue Next Year
  • TARS $42.84
  • KLIC $12.94
  • P/E Ratio
  • TARS N/A
  • KLIC $364.14
  • Revenue Growth
  • TARS 254.45
  • KLIC N/A
  • 52 Week Low
  • TARS $32.91
  • KLIC $26.63
  • 52 Week High
  • TARS $69.49
  • KLIC $52.08
  • Technical
  • Relative Strength Index (RSI)
  • TARS 77.06
  • KLIC 51.25
  • Support Level
  • TARS $56.25
  • KLIC $40.05
  • Resistance Level
  • TARS $59.78
  • KLIC $42.23
  • Average True Range (ATR)
  • TARS 2.58
  • KLIC 1.24
  • MACD
  • TARS 1.15
  • KLIC -0.26
  • Stochastic Oscillator
  • TARS 97.60
  • KLIC 9.05

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

Share on Social Networks: